Literature DB >> 1704034

Truncation analysis of several DR binding epitopes.

D O'Sullivan1, J Sidney, M F Del Guercio, S M Colón, A Sette.   

Abstract

Peptide regions crucial for binding to four different DR alleles (DR1, DR2, DR5, and DR52a) have been localized in five unrelated DR binding peptides (dynorphin 1-13, sperm whale myoglobin 132-153, influenza hemagglutinin 307-319, pigeon cytochrome c 88-104, and tetanus toxoid 830-843) by testing panels of truncated analogs for DR binding. It was found that in most cases, different DR alleles recognize almost identical, albeit distinct, core regions, suggesting that different DR alleles may recognize similar structures on their peptide ligands. Furthermore, it was found that these core regions, notwithstanding their derivation from unrelated sequences, share a common structural pattern. When the sequences of several other unrelated determinants were scrutinized, the structural motif identified was present in some, but absent in other good DR binders, suggesting that good DR binding capacity of peptide molecules may be compatible with more than one single sequence pattern.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

2.  Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule.

Authors:  Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; F Koning
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.

Authors:  M P Davenport; C L Quinn; P Valsasnini; F Sinigaglia; A V Hill; J I Bell
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 5.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

6.  Low abundance of naturally processed T-cell determinants following antigen pulsing of antigen-specific human B-cell lines.

Authors:  S E Moore; J P Schofield; C Watts
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

7.  Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.

Authors:  R Bertoni; J Sidney; P Fowler; R W Chesnut; F V Chisari; A Sette
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

8.  Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.

Authors:  R S van Binnendijk; J P Versteeg-van Oosten; M C Poelen; H F Brugghe; P Hoogerhout; A D Osterhaus; F G Uytdehaag
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets.

Authors:  Christian S Parry
Journal:  BMC Struct Biol       Date:  2008-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.